Nicola S. Vos

Patients with angina and non-obstructive coronary artery disease undergoing comprehensive invasive coronary function testing: long-term clinical outcomes

Caïa Crooijmans, F W Adriaansen, Joan G. Meeder, Marcel A.M. Beijk et autres

BACKGROUND AND AIMS: Comprehensive evaluation by invasive coronary function test (CFT) of patients with angina and non-obstructive coronary artery disease is recommended in current guidelines. The prognosis of patients with CFT-proven coronary vasomotor dysfunction (CVDys) is less well-known. METHODS: Patients that provided …

nl, us (code pays fourni par la source)

Vericiguat for the treatment of coronary vasospasm (ViVA): a double-blind placebo-controlled randomized cross-over trial

Hanae F Namba, Elize A M de Jong, Aukelien C. Dimitriu-Leen, Martijn Meuwissen et autres

nl, gb, es (code pays fourni par la source)

Prevalence of vasomotor dysfunction in patients with residual or recurrent angina after percutaneous coronary intervention

Caïa Crooijmans, Tijn P.J. Jansen, B Yosofi, Fleur W Adriaansen et autres

Prevalence of vasomotor dysfunction in patients with residual or recurrent angina after percutaneous coronary intervention

Caïa Crooijmans, Tijn P.J. Jansen, B Yosofi, Fleur W Adriaansen et autres

Item does not contain fulltext

nl (code pays fourni par la source)

Diagnostic Yield and Safety of Invasive Coronary Function Testing After Radial Versus Femoral Access

Fleur W Adriaansen, Caïa Crooijmans, Tijn P.J. Jansen, B Yosofi et autres

BACKGROUND: Coronary vasomotor dysfunction is diagnosed by a coronary function testing (CFT). However, protocols vary, and the influence of access site and concomitant vasodilator medication on the diagnostic yield and safety of CFT is unclear. This study assessed the diagnostic yield and …

nl (code pays fourni par la source)

26-A-15359-ACC DIAGNOSTIC YIELD AND SAFETY OF INVASIVE CORONARY FUNCTION TESTING AFTER RADIAL VERSUS FEMORAL ACCESS

Fleur W Adriaansen, Caïa Crooijmans, Tijn P.J. Jansen, B Yosofi et autres

Safety, Feasibility, and Diagnostic Yield of Invasive Coronary Function Testing

Caïa Crooijmans, Tijn P.J. Jansen, Joan G. Meeder, Janneke Woudstra et autres

Importance: Patients with angina and no obstructive coronary artery disease frequently have coronary vasomotor dysfunction as underlying pathophysiological mechanism, comprising epicardial spasm, microvascular spasm, and/or microcirculatory dysfunction. These endotypes can be diagnosed by invasive coronary function testing which has previously shown to …

nl (code pays fourni par la source)

Angina Severity and Symptom Improvement Are Associated With Diagnostic Acetylcholine Provocation Dose in Vasospastic Angina

Caïa Crooijmans, Tijn P.J. Jansen, Joan G. Meeder, Valeria Paradies et autres

Background A coronary function test (CFT) is the recommended diagnostic test to identify coronary vasomotor dysfunction as a cause of symptoms in patients with angina and nonobstructive coronary arteries (ANOCA). Acetylcholine is the commonly used pharmacological agent for spasm provocation. We aimed …

nl (code pays fourni par la source)

TCT-678 Angina Severity and Symptom Improvement Are Associated With Diagnostic Acetylcholine Provocation Dose in Vasospastic Angina

Caïa Crooijmans, Tijn P.J. Jansen, Joan G. Meeder, Valeria Paradies et autres

nl (code pays fourni par la source)

5-Year Clinical Outcomes of Paclitaxel-Coated Balloon Angioplasty vs DES in Acute MI

Sander R. Niehe, Nicola S. Vos, René J. van der Schaaf, Giovanni Amoroso et autres

EXpansion of stents after intravascular lithoTripsy versus conventional predilatation in CALCified coronary arteries

Thomas Oomens, Nicola S. Vos, René J. van der Schaaf, Giovanni Amoroso et autres

nl (code pays fourni par la source)

Drug-Coated Balloon Angioplasty in Acute Myocardial Infarction

Nicola S. Vos, Maarten A. Vink

nl (code pays fourni par la source)